Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
433-448
Author(s):
Enrico Garattini, Maurizio Gianni and Mineko Terao
Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
13-28
Author(s):
R. Sinha and K. El-Bayoumy
Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
77-84
Author(s):
G. M. Unger, A. T. Davis, J. W. Slaton and K. Ahmed
Angiogenesis Inhibitors: Current & Future Directions
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1-9
Author(s):
Shaker A. Mousa and Ahmed S. Mousa
Angiogenesis: A Target for Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
11-26
Author(s):
Giampaolo Tortora, Davide Melisi and Fortunato Ciardiello
Resistance to Anti-VEGF Agents
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
51-64
Author(s):
Ton N. C. and Jayson G. C.
Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine
Journal:
Letters in Drug Design & Discovery
Volume:
1
Page:
45-49
Author(s):
G. Ranieri, R. Patruno, G. Fiore, G. Saponaro, A. Paradiso and L. Grammatica
Novel Approaches for Modulating dUTPase and Uracil-DNA Glycosylase: Potential Uses for Cancer and Viral Chemotherapy
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
1
Page:
1-13
Author(s):
A. W. Studebaker, M. E. Ariza, G. K. Balendiran and M. V. Williams
How Much of the Proteome Do We See with Discovery-Based Proteomics Methods and How Much Do We Need to See?
Journal:
Current Proteomics
Volume:
1
Page:
3-12
Author(s):
Scott D. Patterson
Phosphonomethoxyalkyl Analogs of Nucleotides
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
2567-2592
Author(s):
Antonin Holy